NFAT5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.24769999945806E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.78660000027931E-07 |
Normal-vs-Stage2 |
1.75221999999531E-05 |
Normal-vs-Stage3 |
3.90850000142606E-08 |
Normal-vs-Stage4 |
2.70270000046757E-07 |
Stage1-vs-Stage2 |
8.365600E-01 |
Stage1-vs-Stage3 |
1.712490E-02 |
Stage1-vs-Stage4 |
3.115400E-01 |
Stage2-vs-Stage3 |
1.856580E-01 |
Stage2-vs-Stage4 |
4.031800E-01 |
Stage3-vs-Stage4 |
6.028400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.97510000021772E-07 |
Normal-vs-AfricanAmerican |
4.13800000043096E-07 |
Normal-vs-Asian |
3.099800E-02 |
Caucasian-vs-AfricanAmerican |
9.692000E-01 |
Caucasian-vs-Asian |
3.514500E-02 |
AfricanAmerican-vs-Asian |
2.333700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.68350000051554E-07 |
Normal-vs-Female |
5.19480000016337E-07 |
Male-vs-Female |
3.118800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.29750000002582E-06 |
Normal-vs-Age(41-60Yrs) |
1.3879000000383E-06 |
Normal-vs-Age(61-80Yrs) |
6.27409999509609E-08 |
Normal-vs-Age(81-100Yrs) |
5.91180000508729E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.228200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.912600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.532570E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.381500E-03 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.524300E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.045200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.016820E-04 |
Normal-vs-Grade 2 |
7.20359999983877E-07 |
Normal-vs-Grade 3 |
9.13090000276284E-08 |
Normal-vs-Grade 4 |
1.08079999949773E-07 |
Grade 1-vs-Grade 2 |
1.167620E-01 |
Grade 1-vs-Grade 3 |
5.454300E-02 |
Grade 1-vs-Grade 4 |
1.648050E-02 |
Grade 2-vs-Grade 3 |
7.116200E-02 |
Grade 2-vs-Grade 4 |
1.213620E-01 |
Grade 3-vs-Grade 4 |
5.598800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
5.7897000005358E-07 |
Normal-vs-ccB subtype |
5.95900000011085E-07 |
ccA subtype-vs-ccB subtype |
9.227200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.05679999990494E-07 |
Normal-vs-N1 |
7.2451999999501E-07 |
N0-vs-N1 |
4.056200E-01 |
|
|